Stock Events

Stock Events

Elixxer 

$0.033500
5
-$0.00-0%Tuesday 20:00

Statistics

Day High
0.0355
Day Low
0.0355
52W High
0.08
52W Low
0.0059
Volume
4,600
Avg. Volume
0
Mkt Cap
3.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0
0
0.01
Expected EPS
N/A
Actual EPS
-0.0061

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-499,403.44Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap370.33M
Canopy Growth Corporation is a competitor because it operates in the cannabis sector, offering similar products and services as Elixxer, targeting the same market segment.
Aurora Cannabis
ACB
Mkt Cap248.18M
Aurora Cannabis is a direct competitor in the cannabis industry, producing and distributing medical marijuana products which overlap with Elixxer's offerings.
Tilray Brands
TLRY
Mkt Cap533.49M
Tilray is involved in the research, cultivation, production, and distribution of medical cannabis and cannabinoids, making it a competitor to Elixxer in the cannabis market.
Cronos Group
CRON
Mkt Cap1.19B
Cronos Group is a competitor due to its global presence in the cannabis industry, directly competing with Elixxer in several markets for both recreational and medicinal cannabis products.
SNDL
SNDL
Mkt Cap305.19M
Sundial Growers is involved in the production, distribution, and sale of cannabis for the adult-use market, making it a competitor to Elixxer.
Organigram Global
OGI
Mkt Cap137.39M
OrganiGram Holdings is a producer and seller of medical and recreational cannabis, directly competing with Elixxer in the cannabis market.

About

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Show More
CEO
Karim Mecklai
Country
Canada
ISIN
CA28660W2004
WKN
000A3DWCQ

Listings

OTC Link
US
ELIXF
V
CA
ELXR-H.V

0 Comments

Share your thoughts

FAQs

What is Elixxer stock price today?▼
The current price of ELIXF is $0.03 USD — it has decreased by -0% in the past 24 hours. Watch Elixxer stock price performance more closely on the chart.
What is Elixxer stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Elixxer stocks are traded under the ticker ELIXF.
Is Elixxer stock price growing?▼
ELIXF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Elixxer has showed a -58.12% decrease.
What is Elixxer market cap?▼
Today Elixxer has the market capitalization of 3.19M
What were Elixxer earnings last quarter?▼
ELIXF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elixxer revenue for the last year?▼
Elixxer revenue for the last year amounts to 0 USD.
What is Elixxer net income for the last year?▼
ELIXF net income for the last year is -499,403.44 USD.
In which sector is Elixxer located?▼
Elixxer operates in the Health & Wellness sector.
When did Elixxer complete a stock split?▼
The last stock split for Elixxer was on February 10, 2022 with a ratio of 1:100.
Where is Elixxer headquartered?▼
Elixxer is headquartered in Toronto, Canada.